trial

A Study of FK199B to Compare Efficacy With Zolpidem by Polysomnography in Patients With Insomnia

NCTId NCT00999219
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Completed
Enrollment 55 (actual)
Sponsored by Astellas Pharma Global Development, Inc.
Primary completion 2007-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Completed
Enrollment
55 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Quadruple
Start
2006-03
Primary completion
2007-07
Eligibility
ALL · 20 Years · 65 Years

Interventions & indications

Drugs
FK199BZolpidem

Sponsors

Astellas Pharma Global Development, Inc.Lead Sponsor

Investigators

1
Use Central ContactStudy Chair

Sites

0 total

Linked catalysts

1
A Study of FK199B to Compare Efficacy With Zolpidem by Polysomnography in Patien — primary completion2007-07

Facts & assertions

4 sourced
Enrollment
55
Phase
PHASE3
Primary Completion Date
2007-07
Status
COMPLETED
relationships
The graph out of here
drug
FK199B
drug
Zolpidem
drug
lead_sponsor
Astellas Pharma Global Development, Inc.
company
indication
Sleep Initiation and Maintenance Disorders
indication
Sleep Initiation and Maintenance Disorders
indication
investigator
Use Central Contact
person